The risk of cancer in people with diabetes and chronic kidney disease.

BACKGROUND Diabetes and chronic kidney disease (CKD) are both associated with an increased risk of cancer but it is unclear whether diabetes complicated by CKD further augments an individual's cancer risk. The aim of our study was to determine the association of CKD [defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min] with the overall and site-specific risks of incident cancers among individuals with Type 2 diabetes. METHODS Cox proportional hazard regression models and competing risk analyses were used to examine the univariate and multivariate adjusted associations between reduced kidney function and the overall and site-specific risks of cancer in participants enrolled in the Action in Diabetes and Vascular disease: Preterax and Diamicron MR controlled evaluation (ADVANCE) trial. RESULTS Over a median follow-up of 5.0 years, 700 malignant neoplasms occurred in the 11 140 (6.4%) participants. There was no increase in overall cancer risk [adjusted hazard ratio: 1.07 (95% confidence interval: 0.89-1.29, P = 0.50)] or site-specific cancer risk for individuals with CKD (defined as eGFR < 60 mL/min) compared to those without CKD at baseline. These results were robust to multiple methods and thresholds used to estimate CKD. CONCLUSIONS Mild to moderate CKD does not increase the risk of cancer in people with Type 2 diabetes. ADVANCE is registered with ClincalTrial.gov (number NCT00145925).

[1]  Sang Min Park,et al.  Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies , 2011, Canadian Medical Association Journal.

[2]  D. Simon,et al.  Meta-analysis of randomized controlled trials on effect of angiotensin-converting enzyme inhibitors on cancer risk. , 2011, The American journal of cardiology.

[3]  M. Woodward,et al.  Intensive glucose control and risk of cancer in patients with type 2 diabetes , 2011, Diabetologia.

[4]  P. Ganz,et al.  Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort , 2011, Breast Cancer Research and Treatment.

[5]  M. Woodward,et al.  Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  S. Erdman,et al.  Cancer inflammation and regulatory T cells , 2010, International journal of cancer.

[7]  R. Campbell,et al.  Diabetes Mellitus, Inflammation, Obesity: Proposed Treatment Pathways for Current and Future Therapies , 2010, The Annals of pharmacotherapy.

[8]  B. Kupelnick,et al.  Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies. , 2010, American journal of public health.

[9]  L. Stevens,et al.  Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  Henry Völzke,et al.  The predictive value of different measures of obesity for incident cardiovascular events and mortality. , 2010, The Journal of clinical endocrinology and metabolism.

[11]  K. Christensen,et al.  New-onset diabetes mellitus after kidney transplantation in Denmark. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[12]  A. Richmond,et al.  Chemokines and chemokine receptors: new insights into cancer-related inflammation. , 2010, Trends in molecular medicine.

[13]  S. Erdman,et al.  Roles for Inflammation and Regulatory T Cells in Colon Cancer , 2010, Toxicologic pathology.

[14]  I. Godsland,et al.  Insulin resistance-related biomarker clustering and subclinical inflammation as predictors of cancer mortality during 21.5 years of follow-up , 2010, Cancer Causes & Control.

[15]  D. Vlassopoulos,et al.  Inflammatory syndrome in chronic kidney disease: pathogenesis and influence on outcomes. , 2009, Inflammation & allergy drug targets.

[16]  A. Ferrara,et al.  Patients Diagnosed With Diabetes Are at Increased Risk for Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Fibrosis, and Pneumonia but Not Lung Cancer , 2009, Diabetes Care.

[17]  P. Mitchell,et al.  Association of CKD and cancer risk in older people. , 2009, Journal of the American Society of Nephrology : JASN.

[18]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[19]  I. G. Fantus,et al.  High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome , 2009, Breast Cancer Research and Treatment.

[20]  B. Littenberg,et al.  Association of angiotensin-converting enzyme inhibitor therapy and comorbidity in diabetes: results from the Vermont diabetes information system , 2008, BMC endocrine disorders.

[21]  D. Leroith,et al.  Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence. , 2008, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[22]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[23]  Diederick Grobbee,et al.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. , 2008, The New England journal of medicine.

[24]  B. Bammens,et al.  Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM). , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  Ivar Heuch,et al.  Association of albuminuria and cancer incidence. , 2008, Journal of the American Society of Nephrology : JASN.

[26]  P. Meylan,et al.  Cytomegalovirus infection and new‐onset post‐transplant diabetes mellitus , 2007, Clinical transplantation.

[27]  R. Garrick.  Identifying High Risk Groups and Quantifying Absolute Risk of Cancer After Kidney Transplantation: A Cohort Study of 15 183 Recipients , 2008 .

[28]  Nunzia Ruggiero Perrino,et al.  Role of dietary intervention on metabolic abnormalities and nutritional status after renal transplantation. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  R. Bergman,et al.  Metabolic syndrome, hyperinsulinemia, and cancer. , 2007, The American journal of clinical nutrition.

[30]  Alicja Wolk,et al.  Diabetes mellitus and risk of breast cancer: A meta‐analysis , 2007, International journal of cancer.

[31]  C. Mantzoros,et al.  Diabetes mellitus and risk of endometrial cancer: a meta-analysis , 2007, Diabetologia.

[32]  B. Thiers.  Cancer Incidence Before and After Kidney Transplantation , 2007 .

[33]  B. Kiberd.  The chronic kidney disease epidemic: stepping back and looking forward. , 2006, Journal of the American Society of Nephrology : JASN.

[34]  E. Giovannucci,et al.  A Meta-analysis of Diabetes Mellitus and the Risk of Prostate Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[35]  S. Larsson,et al.  Diabetes mellitus and risk of bladder cancer: a meta-analysis , 2006, Diabetologia.

[36]  H. Kauffman.  Malignancies in organ transplant recipients , 2006, Journal of surgical oncology.

[37]  Mitsuhiko Noda,et al.  Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. , 2006, Archives of internal medicine.

[38]  M. Inoue,et al.  Cigarette smoking and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among Japanese. , 2006, Japanese journal of clinical oncology.

[39]  M. Inoue,et al.  Tobacco smoking and breast cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. , 2006, Japanese journal of clinical oncology.

[40]  S. Haffner,et al.  The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. , 2006, The American journal of cardiology.

[41]  S. Larsson,et al.  Diabetes mellitus and risk of colorectal cancer: a meta-analysis. , 2005, Journal of the National Cancer Institute.

[42]  C. Bertozzi,et al.  Glycans in cancer and inflammation — potential for therapeutics and diagnostics , 2005, Nature Reviews Drug Discovery.

[43]  M. Woodward,et al.  Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies , 2005, British Journal of Cancer.

[44]  C. Roberts,et al.  Diabetes and the risk of lung cancer. , 2005, Diabetes care.

[45]  Maria Inês Schmidt,et al.  The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. , 2005, Diabetes care.

[46]  T. Mathew.  Addressing the epidemic of chronic kidney disease in Australia , 2004, Nephrology.

[47]  W. Winkelmayer,et al.  C‐Reactive Protein and Body Mass Index Independently Predict Mortality in Kidney Transplant Recipients , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[48]  H. Adami,et al.  Cancer risk following organ transplantation: a nationwide cohort study in Sweden , 2003, British Journal of Cancer.

[49]  Grupa nadzorująca badanie Advance.  Study rationale and design of ADVANCE: action in diabetes and vascular disease-preterax and diamicron MR controlled evaluation , 2002 .

[50]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[51]  R. Collins,et al.  Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation , 2001 .

[52]  M. Trevisan,et al.  Markers of insulin resistance and colorectal cancer mortality. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[53]  S. Birkeland,et al.  Cancer risk in patients on dialysis and after renal transplantation , 2000, The Lancet.

[54]  G. Hotamisligil.  The role of TNFα and TNF receptors in obesity and insulin resistance , 1999 .

[55]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[56]  G. Hotamisligil.  The role of TNFalpha and TNF receptors in obesity and insulin resistance. , 1999, Journal of internal medicine.

[57]  H. Tsuda,et al.  Implications of the hyperinsulinaemia-diabetes-cancer link for preventive efforts. , 1998, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[58]  A. A. Hart,et al.  Insulin resistance and breast‐cancer risk , 1992, International journal of cancer.